Intellia Therapeutics Presents New In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Society of Gene and Cell Therapy

by NASDAQ Market News April 29, 2019

NASDAQ Market News
Click here to email author

Innovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of Action of Re-normalizing the Intestinal Barrier, to Demonstrate Improvements in validated NASH Biomarkers and Endpoints in synergy with obeticholic acid, an FXR agonist, and Reports key first quarter 2019 financial results and operational highlights

Global Cell Viability Assays & Consumables Market to 2023 – Increasing Focus on Development of Cell-Based Therapeutics & Potential Biomarkers

Ads